Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Registration Number
- NCT01894412
- Lead Sponsor
- Hanwha Chemical
- Brief Summary
The purpose of this study is to compare the safety and pharmacokinetic characteristics of HD203 liquid with those of etanercept (enbrel) prefilled injection after subcutaneous injection
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 48
Inclusion Criteria
- 20 to 40 years of healthy volunteers
Exclusion Criteria
- Subject who had been treated with Etanercept before
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity up to 56 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Hospital🇰🇷Seoul, Korea, Republic of